Standard Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 13.50 Cr
as on 06-12-2024
- Paid Up Capital ₹ 13.41 Cr
as on 06-12-2024
- Company Age 29 Year, 17 Days
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 21.36 Cr
as on 06-12-2024
- Satisfied Charges ₹ 45.30 Cr
as on 06-12-2024
- Revenue 88.86%
(FY 2022)
- Profit -36.53%
(FY 2022)
- Ebitda 68.48%
(FY 2022)
- Net Worth 2.68%
(FY 2022)
- Total Assets 16.27%
(FY 2022)
About Standard Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 13.50 Cr and a paid-up capital of Rs 13.41 Cr.
The company currently has active open charges totaling ₹21.36 Cr. The company has closed loans amounting to ₹45.30 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Standard Pharmaceuticals Ltd India is Tarun Kumar as CFO. Bhabani Dey, Omesh Sethi, and Tarun Kumar serve as directors at the Company.
- CIN/LLPIN
U24232WB1995PLC075698
- Company No.
075698
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
04 Dec 1995
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
Kolkata, West Bengal, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Standard Pharmaceuticals?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Tarun Kumar | CFO | 01-Apr-2013 | Current |
Omesh Sethi  | Managing Director | 30-Sep-2015 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Bhabani Dey | Director | 25-May-2016 | Current |
Financial Performance and Corporate Structure Insights of Standard Pharmaceuticals.
Standard Pharmaceuticals Ltd, for the financial year ended 2022, experienced significant growth in revenue, with a 88.86% increase. The company also saw a substantial fall in profitability, with a 36.53% decrease in profit. The company's net worth moved up by a moderate rise of 2.68%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Standard Pharmaceuticals?
In 2023, Standard Pharmaceuticals had a promoter holding of 93.69% and a public holding of 6.31%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 27 Apr 2018 | ₹1.10 Cr | Open |
Others Creation Date: 25 Aug 2017 | ₹12.85 Cr | Open |
The Federal Bank Limited Creation Date: 01 Nov 1999 | ₹7.41 Cr | Open |
How Many Employees Work at Standard Pharmaceuticals?
Standard Pharmaceuticals has a workforce of 59 employees as of Mar 22, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Standard Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Standard Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
